Calidi Biotherapeutics Announces Corporate Changes
Ticker: CLDWW · Form: 8-K · Filed: Jul 25, 2025 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-appointment, director-election
TL;DR
Calidi Biotherapeutics reshuffled its board and exec team, filed new financials.
AI Summary
Calidi Biotherapeutics, Inc. announced on July 24, 2025, a series of significant corporate actions. These include the election of new directors, the appointment of certain officers, and adjustments to compensatory arrangements. The company also disclosed information regarding Regulation FD, other events, and financial statements and exhibits.
Why It Matters
These changes in leadership and compensation structures can signal shifts in company strategy and governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and officer appointments, along with the filing of financial statements, can introduce uncertainty and signal strategic shifts.
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- July 24, 2025 (date) — Date of earliest event reported
FAQ
Who were the newly elected directors of Calidi Biotherapeutics, Inc.?
The filing indicates the election of directors but does not specify their names in the provided text.
What specific compensatory arrangements were adjusted for certain officers?
The filing mentions adjustments to compensatory arrangements but does not detail the specifics in the provided text.
What is the primary business of Calidi Biotherapeutics, Inc.?
Calidi Biotherapeutics, Inc. is in the business of Biological Products (No Diagnostic Substances), SIC code 2836.
When was Calidi Biotherapeutics, Inc. incorporated?
The company was incorporated in Delaware.
What is the SEC file number for Calidi Biotherapeutics, Inc.?
The SEC file number for Calidi Biotherapeutics, Inc. is 001-40789.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding Calidi Biotherapeutics, Inc. (CLDWW).